Molecule Holdings Inc.
EVRRF
$0.00
$0.000.00%
OTC PK
| 07/31/2023 | 04/30/2023 | 01/31/2023 | 10/31/2022 | 07/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 535.40K | 123.20K | 290.40K | 380.70K | 589.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 535.40K | 123.20K | 290.40K | 380.70K | 589.20K |
| Cost of Revenue | 348.20K | 121.50K | 390.60K | 806.60K | 658.70K |
| Gross Profit | 187.30K | 1.80K | -100.20K | -425.90K | -69.50K |
| SG&A Expenses | 389.30K | 218.60K | 455.90K | 499.00K | 505.30K |
| Depreciation & Amortization | 32.70K | 7.30K | 7.30K | 7.40K | 8.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 770.10K | 347.40K | 853.80K | 1.31M | 1.17M |
| Operating Income | -234.70K | -224.10K | -563.40K | -932.30K | -582.80K |
| Income Before Tax | -589.90K | -477.50K | -505.50K | -1.09M | -578.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -589.90K | -477.50K | -505.50K | -1.09M | -578.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -589.90K | -477.50K | -505.50K | -1.09M | -578.00K |
| EBIT | -234.70K | -224.10K | -563.40K | -932.30K | -582.80K |
| EBITDA | -120.30K | -112.20K | -450.90K | -818.40K | -455.30K |
| EPS Basic | -0.01 | 0.00 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| EPS Diluted | -0.01 | 0.00 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| Average Basic Shares Outstanding | 97.78M | 97.78M | 97.78M | 97.79M | 97.57M |
| Average Diluted Shares Outstanding | 97.78M | 97.78M | 97.78M | 97.79M | 97.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |